Stockhead
 
Biocurious: with fresh grant funding, Emvision’s Emu stroke device won’t take a step backwards

Biocurious: with fresh grant funding, Emvision’s Emu stroke device won’t take a step backwards

With strokes, 'time is brain' and Emvision hopes its Emu and First Responder devices will enable detection in the crucial first hour.

 
Rise and Shine: Everything you need to know before the ASX opens

Rise and Shine: Everything you need to know before the ASX opens

Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today

 
Break it Down: Chariot secures major backing to drive Nigerian exploration

Break it Down: Chariot secures major backing to drive Nigerian exploration

Chariot Corporation raises $1.6 million in a strategic placement to advance its Nigerian lithium portfolio. 

 
Following in the footsteps of De Grey – who will find the next Pilbara gold monster?

Following in the footsteps of De Grey – who will find the next Pilbara gold monster?

With Northern Star’s takeover of De Grey Mining, the search for another Hemi is on in the Pilbara. These explorers are leading the chase.

 
Big pharma takes notice as Novo Nordisk puts Clever Culture’s APAS to the test

Big pharma takes notice as Novo Nordisk puts Clever Culture’s APAS to the test

Clever Culture’s APAS is now on trial with Novo Nordisk, and if it delivers, this one machine could unlock a global pharma rollout.

 
 

Did someone forward this email to you? Subscribe at Stockhead and get it every day.